I respectfully disagree with you for Lumdus for the reasons that I mentioned in my previous messages.. I brought the situation to the attention of Joel Ackerman on the 16th of this month (Saturday)through an email and that is why there was a correction in what was stated in the Israeli newspaper. The Company will not give away any compound without getting something in return for it. As I mentioned, The Company six months ago decided not to in-license any more compunds since the cost to license these compounds and bring them to fruition is simply too much and involves an awful lot of capital. Money people are not willing to place their investments in CSBR for a small slice of the action of new drugs They would rather place it in a Company where they get a bigger slice of the pie. Bringing a compound through testing and marketing is a very expensive and risky business. I believe that CSBR is negotiaiting with Tevi Pharmaceutical, the largest pharmaceutical Company in Israel and one of the largest in the world, to obtain more drugs for its testing on the tumorgraft platform. This will increse the revenues in CSBR. At the same time, they will gain advantage of any cancer curing drug potentail that they discover through their supposed minority interest in the new Company as well as perhaps getting some sort of royalty or other revenue stream fromk these potential cancer curing drugs. I believe that the article mentioned that Sidransky is in Israel on a sabbatical. I believe that Sidransky may be in Israel to negotiate a deal with Tevi. This is the Company that acquired Cephelon with whom CSBR has a contract. For the time being, I believe that CSBR is doing the right thing by operating the Company as frugally as possible while at the same time taking advantage of any drug that it might discover that has good potential. Dr. Sidransky, besides being one of the finest oncologist and scientists in the world, is also a very shrewd business man. If you sell him short you do so at your own investment peril. I have been and still am bullish on CSBR until some strong evidence indicates that I should no longer take that stand. Again, Battery Partners just bought 3,000,000 shares of the Company about a month ago. I am certain that they do not like to throw aweay money. They know something that we do not and that will become apparent soon. For the time being, CSBR investors would be smart to wait for the outcome of Dr. Sidransky's negotiations. If anything, I would be a buyer of CSBR stock at this point. The incentive of management is obvious. Just about all of them have received stock compensation and not monetary compensationm. No person in his right mind would do that if he did not feel that the Comopany had some real good potential to make it big.
